Trading at the lower channel level. Not sure it will get to 200 dma. I was holding off too thinking it would break down to that level. Price action today is saying it might be turning.
well. DRTX is a double from here. CELG could 2X as well.
So typical. Market's reaction was one of not buy, there might be some bad news coming, and the volume is low. Bad scenario. The only news I saw was a manufacturing agreement in Europe was signed. I thought it was good news. Also the 2 new Board members bought shares thought that was good news. Picked up a few hundnred more shares.
Where is that Needham analyst predicting 900K barrels would be exported per day in August? What a nut job. Let's see processing costs to ship,taxes, insurance etc. estimates between $8 to $15 per barrel subtract $7 spread last month (now about $9) that leaves a $6 per barrel loss. Hmm doesn't sound like 900K per day is being exported. Plus the infrastructure isn't there, and the DOE is re-visiting the export variance given to Pioneer. Also imports actually rose last week. How can we export if we are still importing 8M barrels a day. I haven't heard any logic to support exporting.
Would be an astute move for Eagle Ford and more Baken acreage and growth.
Really should consider turning over your finances to a certified financial planner.
and other analysts also factored it into their analysis. Of course morons will probably sell. I will buy some more. The prospects are the same and conservative. If AZN is interested in buying, I doubt this would change their mind. ORBACTIV requires daily injections BTW.
I saw that. I thought it was too big a jump based on the Stanberry buy rating with a PT of $26. Wouldn't be suprised if it were a double.
What does this mean. It means the correction is near over or over. If the GDP came in at 3% it would have been a 10% correction, 2% 10% correctrion. Now the market did a quick purge. With a backdrop of a lets say 3% growth, and low interest rates no one can stay out of the market long like days. Goldilocks in place with the jobs report today, Fed is still on hold. By cyclicals, oil, biotechs, and refiners. Refiners & biotechs have already corrected. MPC and VLO look very compelling. PSX is a good one too.
Apparently they didn't expect the consequences or the impression that it is opening the flood gates for exporting oil without restrictions. Oops, Sorry about that! It wasn't going to amount to much anyway. Way overblown by shorters, hedge funds, ignorant journalists. Based on the hold decision, I see refines testing the old highs in the not too far off future. The decision will take a while to revise, resind...,
It might get acquired like golongin2008 says. I am not sure I am as pesstimistic though on going it alone. TRIUS, I owned, but their drug has already shown signs of resistance. I thought we got scr*wed as shareholders by CBST. Roth Capital is very optimistic about dalbavancin and DRTX going it alone. I would imagine every hospital would have to order some to have on hand.
forever. Don't worry, scooped up about 2K at 12.40. Not quite the low, but who cares. Your shares are in good hands now, you can sleep peacefully. I expect this in the 20' in 6 months high 20's sometime after, maybe 9 or 12 months. IMHO.
What did I say, Analysts would be raising price targets. Right now we are at 12.9X forward PE. All I can say is whoever sold you are a moron. Please seek professional help--that is a financial advisor. You have no business in the stock market. And if you are a professional, please re-sign from your position immediately.
I agree, the headline came from somewhere. I think it is bogus, which is why I'll add to my postion. Probably a hedgefund wanting to set the tone for starting trading. Could have a short or large put postion. Or wants to accumulate.
are downplaying. In any case base on the 12 month trajectory, the price targets will be increased. I am a buyer on any weakness. Which if pre-market is an indication, I'll be adding. IMHO a stellar quarter.
Essentially there are no shares for sales by only but the very few. Not seeing any institutional selling only buying.
Reason to own is they will be bought out. To many starved big Pharm a's for growth and a pipeline.